Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil citrate dispersible tablets PK comparison in children with pulmonary arterial hypertension
CTR20252178Phase 2Active
- Sponsor
- Shanghai Aoxuan Biopharmaceutical Technology
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sildenafil in pulmonary arterial hypertension (PAH), sponsored by Shanghai Aoxuan Biopharmaceutical Technology. Started Jun 2025; status: active.
02
Drugs
sildenafil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on CTR20252178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252178.